These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 7686928

  • 21. Ia-restricted encephalitogenic T lymphocytes mediating EAE lyse autoantigen-presenting astrocytes.
    Sun D, Wekerle H.
    Nature; ; 320(6057):70-2. PubMed ID: 2419764
    [Abstract] [Full Text] [Related]

  • 22. Functional heterogeneity among CD4+ encephalitogenic T cells in recruitment of CD8+ T cells in experimental autoimmune encephalomyelitis.
    Sun D, Klinkert WE.
    J Immunol; 1989 Nov 01; 143(9):2867-72. PubMed ID: 2478627
    [Abstract] [Full Text] [Related]

  • 23. Autoaggressive T lymphocyte lines recognizing the encephalitogenic region of myelin basic protein: in vitro selection from unprimed rat T lymphocyte populations.
    Schluesener HJ, Wekerle H.
    J Immunol; 1985 Nov 01; 135(5):3128-33. PubMed ID: 2413113
    [Abstract] [Full Text] [Related]

  • 24. Two-domain MHC class II molecules form stable complexes with myelin basic protein 69-89 peptide that detect and inhibit rat encephalitogenic T cells and treat experimental autoimmune encephalomyelitis.
    Burrows GG, Bebo BF, Adlard KL, Vandenbark AA, Offner H.
    J Immunol; 1998 Dec 01; 161(11):5987-96. PubMed ID: 9834080
    [Abstract] [Full Text] [Related]

  • 25. Experimental autoimmune encephalomyelitis: the antigen specificity of T lymphocytes determines the topography of lesions in the central and peripheral nervous system.
    Berger T, Weerth S, Kojima K, Linington C, Wekerle H, Lassmann H.
    Lab Invest; 1997 Mar 01; 76(3):355-64. PubMed ID: 9121118
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Immune regulation by brain cells in the central nervous system: microglia but not astrocytes present myelin basic protein to encephalitogenic T cells under in vivo-mimicking conditions.
    Matsumoto Y, Ohmori K, Fujiwara M.
    Immunology; 1992 Jun 01; 76(2):209-16. PubMed ID: 1378815
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Experimental autoimmune encephalomyelitis mediated by T lymphocyte lines: genotype of antigen-presenting cells influences immunodominant epitope of basic protein.
    Beraud E, Reshef T, Vandenbark AA, Offner H, Friz R, Chou CH, Bernard D, Cohen IR.
    J Immunol; 1986 Jan 01; 136(2):511-5. PubMed ID: 2416808
    [Abstract] [Full Text] [Related]

  • 31. Heterogeneity of rat encephalitogenic T cells elicited by variants of the myelin basic protein (68-86) peptide.
    Sun D, Coleclough C, Hu XZ.
    Eur J Immunol; 1995 Jun 01; 25(6):1687-92. PubMed ID: 7542200
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Selection of encephalitogenic rat T-lymphocyte clones recognizing an immunodominant epitope on myelin basic protein.
    Chou YK, Vandenbark AA, Jones RE, Hashim G, Offner H.
    J Neurosci Res; 1989 Feb 01; 22(2):181-7. PubMed ID: 2468787
    [Abstract] [Full Text] [Related]

  • 34. A TCR V alpha CDR3-specific motif associated with Lewis rat autoimmune encephalomyelitis and basic protein-specific T cell clones.
    Buenafe AC, Tsu RC, Bebo B, Bakke AC, Vandenbark AA, Offner H.
    J Immunol; 1997 Jun 01; 158(11):5472-83. PubMed ID: 9164970
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Immunomodulation of experimental autoimmune encephalomyelitis by staphylococcal enterotoxin D.
    Matsumoto Y, Fujiwara M.
    Cell Immunol; 1993 Jul 01; 149(2):268-78. PubMed ID: 7687198
    [Abstract] [Full Text] [Related]

  • 39. Intercellular exchange of class II major histocompatibility complex/peptide complexes is a conserved process that requires activation of T cells but is constitutive in other types of antigen presenting cell.
    Patel DM, Mannie MD.
    Cell Immunol; 2001 Dec 15; 214(2):165-72. PubMed ID: 12088415
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.